CDW Corp. vs Enveric Biosciences Inc — how do they compare? CDW Corp. trades at $144.5 (market cap $18.44B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: CDW Corp. is far larger — about 3440.3× Enveric Biosciences Inc's market cap, and CDW Corp. pays a 1.75% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| CDW | ENVB | |
|---|---|---|
Market Cap | $18.44B | $5.36M |
Sector | Technology | Health |
52-Week High | $182.18 | $17.40 |
52-Week Low | $99.30 | $1.28 |
Enterprise Value | $23.65B | $449.11K |
Dividend Yield | 1.75% | — |
Trailing returns across standard periods
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →